MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D8A525.B25668D0"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA66280101_8982.files/filelist.xml">
<link rel=3DPreview href=3D"UA66280101_8982.files/preview.wmf">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Пользователь</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:LastPrinted>2019-12-26T06:22:00Z</o:LastPrinted>
  <o:Created>2022-07-31T18:37:00Z</o:Created>
  <o:LastSaved>2022-07-31T18:37:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1557</o:Words>
  <o:Characters>8875</o:Characters>
  <o:Company>Microsoft</o:Company>
  <o:Lines>73</o:Lines>
  <o:Paragraphs>20</o:Paragraphs>
  <o:CharactersWithSpaces>10412</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
  <o:TargetScreenSize>800x600</o:TargetScreenSize>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"UA66280101_8982.files/item0001.xml"
target=3D"UA66280101_8982.files/props002.xml">
<link rel=3DthemeData href=3D"UA66280101_8982.files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"UA66280101_8982.files/colorschememap=
ping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Shading Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light List Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Light Grid Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 1 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Shading 2 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 1 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium List 2 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 1 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 2 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Medium Grid 3 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Dark List Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Shading Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful List Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Colorful Grid Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
h2
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 2 Знак";
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок Знак";
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:1.0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Основной текст с отступом Знак";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Основной текст 2 Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;}
span.2
	{mso-style-name:"Заголовок 2 Знак";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 2";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:RU;
	font-weight:bold;}
span.a
	{mso-style-name:"Основной текст с отступом Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Основной текст с отступом";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:RU;}
span.20
	{mso-style-name:"Основной текст 2 Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Основной текст 2";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:RU;}
span.a0
	{mso-style-name:"Заголовок Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Заголовок;
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-fareast-language:RU;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.a1, li.a1, div.a1
	{mso-style-name:"";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Название Знак";
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:1.0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.a2
	{mso-style-name:"Название Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"";
	mso-ansi-font-size:12.0pt;
	mso-ansi-language:UK;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Normal, li.Normal, div.Normal
	{mso-style-name:Normal;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	layout-grid-mode:line;}
p.a3, li.a3, div.a3
	{mso-style-name:"";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:1.0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.FR3, li.FR3, div.FR3
	{mso-style-name:FR3;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:2.0pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:34.0pt;
	line-height:200%;
	mso-pagination:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	layout-grid-mode:line;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:2.0cm 42.55pt 2.0cm 42.55pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:35.4pt'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal;page-break-after:avoid;mso-outline-lev=
el:
2'><b><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>ІНСТРУКЦІЯ<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>для медичного застосування лі=
карського
засобу<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>ВАЗАВІТАЛ<sup>®</sup><span style=3D'mso-bidi-font-weight:bold'><o:p></o=
:p></span></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><b style=3D'mso-bidi-font-we=
ight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>Склад:<o:p></o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:-2.8pt;margin-bot=
tom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:no=
rmal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>діючі речовини:</span></i><sp=
an
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'> сухий екстракт гінкго білоби (<i style=3D'mso-bidi-font-style:normal'>=
ginkgo
biloba</i> L.), обніжжя бджолине (квітковий пилок), рутин (вітамін Р),
аскорбінова кислота<span style=3D'mso-spacerun:yes'>  </span>(вітамін С),<s=
pan
style=3D'mso-spacerun:yes'>  </span>нікотинова<span style=3D'mso-spacerun:y=
es'> 
</span>кислота<span style=3D'mso-spacerun:yes'>  </span>(вітамін РР),<span
style=3D'mso-spacerun:yes'>  </span>тіаміну<span style=3D'mso-spacerun:yes'=
> 
</span>гідрохлорид (вітамін В<sub>1</sub>), рибофлавін (вітамін В<sub>2</su=
b>),
піридоксину гідрохлорид (вітамін В<sub>6</sub>);<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:-2.8pt;margin-bot=
tom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:no=
rmal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>1 капсула містить сухого екстракту гінкго білоби (<i style=3D'mso-bidi-=
font-style:
normal'>ginkgo biloba</i> L.) (співвідношення вихідного матеріалу до одержа=
ного
екстракту 50:1; екстрагент етанол 60 %) 40 мг, обніжжя бджолиного (квітково=
го пилку)
60 мг, рутину (вітаміну Р) 20 мг, аскорбінової кислоти<span
style=3D'mso-spacerun:yes'>  </span>(вітаміну С) 30 мг,<span
style=3D'mso-spacerun:yes'>  </span>нікотинової<span style=3D'mso-spacerun:=
yes'> 
</span>кислоти<span style=3D'mso-spacerun:yes'>  </span>(вітаміну РР)<span
style=3D'mso-spacerun:yes'>  </span>17 мг,<span style=3D'mso-spacerun:yes'> 
</span>тіаміну<span style=3D'mso-spacerun:yes'>  </span>гідрохлориду (вітам=
іну В<sub>1</sub>)
1 мг, рибофлавіну (вітаміну В<sub>2</sub>) 1 мг, піридоксину гідрохлориду
(вітаміну В<sub>6</sub>) 1 мг;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>допоміжні речовини:</span></i=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'> лактоза, моногідрат; магнію стеарат;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>склад оболонки капсули: </span></i><span lang=3DUK style=3D'font-size:1=
2.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>желатин, титану діоксид (Е 17=
1),
індигокармін (Е 132), хіноліновий жовтий (Е 104).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Лікарська форма. </span></b><=
span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Капсули.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"=
Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
UK'>Основні фізико-хімічні властивості:</span></i><span lang=3DUK
style=3D'font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New =
Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
UK'> т</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU;mso-bidi-font-weight:bold'>верді желатинові капсули циліндричної форми з
напівсферичними кінцями, корпус капсули білого кольору, кришечка – зеленого
кольору. Вміст капсули – порошок світло-коричневого кольору з приємним запа=
хом.
Допускаються включення темного та світлого кольорів.</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Фармакотерапевтична група. <o=
:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Засоби, що застосовуються при деменції. Код АТХ
N06D X.<b><o:p></o:p></b></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Фармакологічні властивості.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU;mso-bidi-font-weight:bold'>Фармакодинаміка. <o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Вазавітал</span><sup><span lang=3DUK
style=3D'font-size:12.0pt;font-family:Symbol;mso-ascii-font-family:"Times N=
ew Roman";
mso-fareast-font-family:"Times New Roman";mso-hansi-font-family:"Times New =
Roman";
mso-ansi-language:UK;mso-fareast-language:RU;mso-char-type:symbol;mso-symbo=
l-font-family:
Symbol'><span style=3D'mso-char-type:symbol;mso-symbol-font-family:Symbol'>=
&Ograve;</span></span></sup><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'> – комбінований препарат рослинного походження, до складу якого входять
вітаміни. <span style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Містить <i style=3D'mso-bidi-font-style:normal'=
>екстракт
листя гінкго білоби.</i> Активними діючими компонентами гінкго білоби є
флавонові глікозиди і терпени – гінколіди і білобаліди, а також
проантоціанідини та органічні кислоти, які зумовлюють підвищену біодоступні=
сть
компонентів препарату та збільшують специфічну активність Вазавіталу</span>=
<sup><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:14.0pt;font-family:"=
Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>®</span></sup><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Ti=
mes New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>. В основі фармакологічної дії екстракту листків гінкго білоби лежить й=
ого
здатність пригнічувати процеси вільнорадикального окиснення, що є важливим
фактором ушкодження тканин при ішемії та гіпоксії. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Препарат впливає на утворення вазоактивних
медіаторів та медіаторів запалення, що зумовлює його здатність покращувати
кровообіг та чинити протинабрякову дію. Препарат знижує ризик тромбоутворен=
ня,
нормалізує процеси клітинного обміну, збільшує вміст АТФ у корі головного
мозку, позитивно впливає на обмін дофаміну та норадреналіну, а також на
холінергічну передачу. Покращує кровозабезпечення тканин завдяки регулюючому
впливу на кровотік в артеріях, капілярах та венах.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Обніжжя бджолине (квітковий пилок)</span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'> містить
біологічно активні речовини (незамінні амінокислоти, ненасичені жирні кисло=
ти),
необхідні для регенерації клітин. Квітковий пилок чинить протисклеротичну д=
ію,
знижує кількість холестерину в крові та виводить його з організму. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Домінуючі у складі пилку рутин та кверцетин
покращують еластичність кров’яних капілярів та їх проникність. Флавоноїди т=
акож
чинять помірну антигістамінну, антиоксидантну та детоксикуючу дії.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Аскорбінова кислота (вітамін С).</span></i><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'> Нормалізує проникність
капілярів, сприяє підвищенню захисних функцій організму, запобігає утворенню
тромбів, сприяє насиченню тканин киснем.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Нікотинова кислота (вітамін РР).</span></i><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'> Бере участь у реакціях
енергетичного обміну організму.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Тіаміну гідрохлорид (вітамін В<sub>1</sub>). </span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'>Відіграє
першочергову роль в оптимальній утилізації вуглеводів, які є основним джере=
лом
енергії, регулює функцію периферичної нервової системи.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Рибофлавін (вітамін В<sub>2</sub>).</span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'> Бере участ=
ь у
процесах росту, впливає на зір, стан шкіри, його активні фосфорильовані фор=
ми
беруть участь у регулюванні окиснювально-відновлювальних процесів.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Піридоксину гідрохлорид (вітамін В<sub>6</sub>).</span></i><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'> Необхідний=
 для
засвоєння білків та жирів, сприяє утворенню еритроцитів, регулює стан нерво=
вої
системи.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Рутин (вітамін Р). </span></i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Ангіопротектор, зменшує підви=
щену
проникність капілярів, укріплює судинну стінку, зменшує її набряк та запале=
ння.
Чинить антиагрегантну дію, чим покращує мікроциркуляцію, затримує розвиток
діабетичної ретинопатії.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Клінічні характеристики.<o:p>=
</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Показання.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Призначають дорослим для профілактики та у
комплексному лікуванні:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>– дисциркуляторної енцефалопатії з порушеннями
уваги, пам’яті, сприйняття, зниженням інтелектуальної спроможності;<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>–<span style=3D'mso-spacerun:yes'>   </span>при
початковій стадії хвороби Альцгеймера;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>– нейросенсорних порушень: кохлеовестибулярний
синдром (шум у вухах, гіпоакузія, запаморочення);<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>–<span style=3D'mso-spacerun:yes'> 
</span>діабетичної ретинопатії;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>–<span style=3D'mso-spacerun:yes'> 
</span>артеріопатії нижніх кінцівок (біль при ходьбі, трофічні порушення); =
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>–<span style=3D'mso-spacerun:yes'>  </span>синд=
рому
Рейно.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Протипоказання.<span style=3D'mso-spacerun:yes'>  </span><o:p></o:p></s=
pan></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Підвищена чутливість до компонентів препарату.<span
style=3D'mso-spacerun:yes'>  </span>Нефролітіаз,<span style=3D'mso-spacerun=
:yes'> 
</span>тромбофлебіт,<span style=3D'mso-spacerun:yes'>  </span>порушення<span
style=3D'mso-spacerun:yes'>  </span>обміну заліза або міді, виражені поруше=
ння
функції нирок, виразкова хвороба шлунка та дванадцятипалої кишки у стадії з=
агострення,
подагра, гіперурикемія.<a name=3D"_GoBack"></a><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Взаємодія з іншими лікарськими засобами та інші види взаємодій. <o:p></=
o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Результати клінічних досліджень взаємодії гінкго
білоби продемонстрували потенціювання або інгібування ізоферментів цитохрому
Р450. Рівень концентрації мідазоламу змінювався після супутнього прийому гі=
нкго
білоби, що дозволяє припускати наявність взаємодії через CYP3A4. Тому лікар=
ські
засоби, які в основному метаболізуються через CYP3A4 і мають вузький
терапевтичний індекс, слід застосовувати з обережністю.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Препарат не слід приймати, якщо пацієнт тривалий
час застосовує ацетилсаліцилову кислоту, варфарин або тіазидні діуретики.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>При одночасному застосуванні препарату з
лікарськими засобами, що інгібують коагуляцію крові (такими як фенпрокумон,
ацетилсаліцилова кислота та інші нестероїдні протизапальні засоби), ефект
останніх може посилитися. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Через підвищений ризик кровотеч слід уникати
одночасного прийому препарату з антикоагулянтами, антиагрегантами. Геморагії
можуть посилитися при одночасному прийомі препарату з хініном. Вітамін С
посилює дію протимікробних лікарських засобів із групи сульфаніламідів.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><b style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Особливості застосування.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>При патологічно підвищеній тенденції до кровотеч
(геморагічний діатез), а також у разі одночасного застосування антикоагулян=
тів
препарат необхідно приймати тільки після консультації з лікарем. <o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Оскільки є дані, що препарати, які містять екст=
ракт
гінкго білоби, підвищують схильність до кровотеч, прийом цього препарату
необхідно припинити перед хірургічними операціями. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>З обережністю призначають при виразковій хворобі
шлунка і дванадцятипалої кишки в анамнезі, сечокам’яній хворобі, при уражен=
ні
печінки, пацієнтам із захворюванням нирок в анамнезі, схильністю до
тромбоутворення та кровотеч (гемофілія, тромбоцитопенія, тромбоцитопатії то=
що),
алергічні захворювання. Препарат не рекомендується призначати разом з іншими
полівітамінами, оскільки можливе передозування останніх в організмі. Не слід
перевищувати рекомендовану дозу препарату.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Препарат містить лактозу, тому пацієнтам із
рідкісними спадковими формами непереносимості галактози, дефіцитом лактази =
або
синдромом мальабсорбції глюкози-галактози не слід його застосовувати.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Рекомендується уважно спостерігати за пацієнтам=
и, які
одночасно приймають препарати, що метаболізуються цитохромом Р450 3А4.
Відомості про передозування гінкго білоби відсутні. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Препарат містить лактозу, тому пацієнти з
рідкісними спадковими формами непереносимості галактози, недостатністю лакт=
ази
або синдромом глюкозо-галактозної мальабсорбції не повинні застосовувати пр=
епарат.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><b style=3D'mso-bidi-font-we=
ight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Застосування у період вагітності або годування груддю</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>У зв’язку з відсутністю кліні=
чних
даних препарат не рекомендується застосовувати у період вагітності або
годування груддю.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><b style=3D'mso-bidi-font-we=
ight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Здатність впливати на швидкість реакції при керуванні автотранспортом а=
бо
іншими механізмами.</span></i><span lang=3DUK style=3D'font-size:12.0pt;fon=
t-family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>Досліджень з оцінки впливу на
швидкість реакції при керуванні автотранспортом або іншими механізмами не
проводилося. Проте запаморочення може погіршити здатність керувати автомобі=
лем
або іншими механізмами.<b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></b></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Спосіб застосування та дози. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Дорослим </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-fami=
ly:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>призначають по 1 капсулі 3 рази на добу. Приймають під час вживання їжі=
, запиваючи
<br>
&frac12; склянки води. Курс лікування визначається лікарем індивідуально і
зазвичай становить <br>
1-3 місяці 2 рази на рік. Початок терапевтичного ефекту настає через 7 днів
лікування. Найбільш виражений ефект спостерігається через 3 тижні після при=
йому
препарату. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><b style=3D'mso-bidi-font-we=
ight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'fo=
nt-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Діти.</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"=
Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>Не застосовувати дітям.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Передозування. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:131.15pt'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Симптоми:</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-fami=
ly:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'> можливе посилення проявів побічних реакцій, біль у животі, нудота,
блювання, здуття живота, порушення функції нирок, алергічні висипання на шк=
ірі,
свербіж, головний біль, підвищена збудливість, порушення свідомості. <o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:131.15pt'><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>При тривалому застосуванні
високих доз можливе виникнення анорексії, порушень активності печінкових
ферментів, парестезій, підвищеної пітливості, артеріальної гіпотензії,
гіперурикемії, відчуття жару. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:131.15pt'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Лікування: </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-fa=
mily:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>необхідно викликати блювання. Терапія
симптоматична.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.0pt'><b><i style=3D'mso-bidi-font-=
style:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'><span style=3D'mso-tab-count:1'>                                       =
                    </span><o:p></o:p></span></i></b></p>

<b><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",=
"serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:alwa=
ys'>
</span></b>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Побічні реакції.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU;mso-bidi-font-weight:bold'>Зрідка спостерігаються
наступні реакції:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-outline-level:1'><i style=3D'mso-bidi-font-s=
tyle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>з боку імунної системи: </span></i><span lang=3DUK style=3D'font-size:1=
2.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>реакції гіперчутливості,
алергічні реакції, включаючи анафілактичний шок, ангіоневротичний набряк,
кропив’янку, задишку, бронхоспазм, гіпертермію;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-outline-level:1'><i style=3D'mso-bidi-font-s=
tyle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU;mso-bidi-font-weight:bold'>з боку травної системи: </span></i><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU;mso-bidi-fon=
t-weight:
bold'>розлади травлення, нудота, блювання, </span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'>діарея,
диспепсія, абдомінальний біль, збільшення секреції шлункового соку;<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU;mso-bidi-font-weight:bold'>з боку нервової системи:</span></i><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU;mso-bidi-fon=
t-weight:
bold'> головний біль, запаморочення, синкопе (у тому числі вазовагальне);<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU;mso-bidi-font-weight:bold'>з боку шкіри: </span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU;mso-bidi-fon=
t-weight:
bold'>запалення шкіри, почервоніння, набряк, свербіж, висипання, </span><sp=
an
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>кропив’янка, екзема;<span style=3D'mso-bidi-font-weight:bold'><o:p></o:=
p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-outline-level:1'><i style=3D'mso-bidi-font-s=
tyle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Інші: </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>зниження згортання крові, зміна кольору сечі.<i style=3D'mso-bidi-font-=
style:
normal'><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>У поодиноких випадках при застосуванні препарат=
ів,
що містять екстракт гінкго білоби, особливо при одночасному застосуванні з
антикоагулянтами (такими як фенпрокумон, ацетилсаліцилова кислота та інші
нестероїдні протизапальні засоби), виникають крововиливи (шлунково-кишкові,=
 в
очі, у мозок).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Термін придатності. <o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>2 роки.<b><o:p></o:p></b></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;tab-stops:177.75pt'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Ro=
man","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Не застосовувати препарат після закінчення терміну придатності, зазначе=
ного
на упаковці.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Умови зберігання. <o:p></o:p>=
</span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Зберігати в оригінальній упаковці при температу=
рі
не вище 25 </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:Sym=
bol;
mso-ascii-font-family:"Times New Roman";mso-fareast-font-family:"Times New =
Roman";
mso-hansi-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-la=
nguage:
RU;mso-char-type:symbol;mso-symbol-font-family:Symbol'><span style=3D'mso-c=
har-type:
symbol;mso-symbol-font-family:Symbol'>°</span></span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast=
-font-family:
"Times New Roman";mso-ansi-language:UK;mso-fareast-language:RU'>С.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Зберігати у недоступному для дітей місці.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Упаковка. <o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:-5.75pt;margin-bo=
ttom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:no=
rmal;
mso-pagination:none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>По 10 капсул у блістері. По 3 блістери у коробці з картону.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:-5.75pt;margin-bo=
ttom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:no=
rmal;
mso-pagination:none'><span lang=3DUK style=3D'font-size:12.0pt;font-family:=
"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>По 90 капсул у банці полімерній. По 1 банці у коробці з картону.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Категорія відпуску. <o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'>Без рецепта.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Виробник.<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>ТОВ «А<span style=3D'text-tra=
nsform:
uppercase'>страфарм</span>».<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Місцезнаходження виробника та
його адреса місця провадження діяльності.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>Україна, 08132, Київська обл.,
Києво-Святошинський район, м. Вишневе, вул. Київська, 6.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Виробник.<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>ПрАТ «Біолік».<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Ro=
man";
mso-ansi-language:UK;mso-fareast-language:RU'>Місцезнаходження виробника та
його адреса місця провадження діяльності.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>Україна, 24321, Вінницька обл=
.,
м. Ладижин, вул. Незалежності, 131, Ш.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";mso-ans=
i-language:
UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
style=3D'font-size:12.0pt;line-height:90%;font-family:"Times New Roman","se=
rif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Заявник.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>ТОВ «Українська фармацевтична
компанія».<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
style=3D'font-size:12.0pt;line-height:90%;font-family:"Times New Roman","se=
rif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:UK;mso-fareast-=
language:
RU'>Місцезнаходження заявника.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'>Україна, 02660, м. Київ, вул.
Старосільська, 1 У. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:90%'><span lang=3DUK style=3D'font-size:12.0pt;line-hei=
ght:
90%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times Ne=
w Roman";
mso-ansi-language:UK;mso-fareast-language:RU'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&n=
bsp;</o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<b:Sources SelectedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns:b=3D"http://s=
chemas.openxmlformats.org/officeDocument/2006/bibliography" xmlns=3D"http:/=
/schemas.openxmlformats.org/officeDocument/2006/bibliography"></b:Sources>

------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{F2F703F4-453D-48FE-96AD-545BFF6E4E89}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D8A525.B25668D0
Content-Location: file:///C:/680CEB32/UA66280101_8982.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA66280101_8982.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D8A525.B25668D0--
